Trexquant Investment’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.6M | Buy |
58,431
+12,752
| +28% | +$4.73M | 0.13% | 159 |
|
|
2026
Q1 | $13.4M | Buy |
+45,679
| New | +$15M | 0.1% | 279 |
|
|
2025
Q3 | – | Sell |
-64,732
| Closed | -$25.2M | – | 1680 |
|
|
2025
Q2 | $25.2M | Buy |
64,732
+62,976
| +3,586% | +$25.3M | 0.28% | 51 |
|
|
2025
Q1 | $764K | Buy |
+1,756
| New | +$705K | 0.01% | 1172 |
|
|
2024
Q4 | – | Sell |
-44,048
| Closed | -$22.9M | – | 1630 |
|
|
2024
Q3 | $22.9M | Buy |
+44,048
| New | +$23.5M | 0.29% | 62 |
|
|
2024
Q1 | – | Sell |
-27,886
| Closed | -$13.1M | – | 1511 |
|
|
2023
Q4 | $13.1M | Sell |
27,886
-5,887
| -17% | -$2.72M | 0.3% | 67 |
|
|
2023
Q3 | $14.7M | Sell |
33,773
-4,294
| -11% | -$1.95M | 0.37% | 38 |
|
|
2023
Q2 | $16.9M | Buy |
38,067
+10,761
| +39% | +$4.96M | 0.44% | 29 |
|
|
2023
Q1 | $12.6M | Buy |
27,306
+13,221
| +94% | +$6.29M | 0.34% | 49 |
|
|
2022
Q4 | $7.23M | Sell |
14,085
-8,275
| -37% | -$4.2M | 0.2% | 122 |
|
|
2022
Q3 | $10.2M | Buy |
22,360
+12,782
| +133% | +$6.12M | 0.36% | 55 |
|
|
2022
Q2 | $4.62M | Buy |
+9,578
| New | +$4.74M | 0.21% | 105 |
|
|
2021
Q3 | – | Sell |
-6,487
| Closed | -$2.48M | – | 1225 |
|
|
2021
Q2 | $2.48M | Buy |
+6,487
| New | +$2.48M | 0.21% | 137 |
|
|
2021
Q1 | – | Sell |
-5,600
| Closed | -$1.8M | – | 1199 |
|
|
2020
Q4 | $1.8M | Sell |
5,600
-1,821
| -25% | -$559K | 0.19% | 138 |
|
|
2020
Q3 | $1.99M | Sell |
7,421
-2,197
| -23% | -$591K | 0.13% | 223 |
|
|
2020
Q2 | $2.53M | Sell |
9,618
-107
| -1% | -$28.5K | 0.18% | 157 |
|
|
2020
Q1 | $2.21M | Buy |
+9,725
| New | +$2.65M | 0.16% | 189 |
|
|
2019
Q4 | – | Sell |
-38,936
| Closed | -$9.35M | – | 1086 |
|
|
2019
Q3 | $9.35M | Buy |
+38,936
| New | +$10.7M | 0.81% | 2 |
|
|
2019
Q2 | – | Sell |
-13,225
| Closed | -$3.79M | – | 890 |
|
|
2019
Q1 | $3.79M | Buy |
+13,225
| New | +$3.82M | 0.27% | 97 |
|
|
2018
Q2 | – | Sell |
-1,277
| Closed | -$281K | – | 975 |
|
|
2018
Q1 | $281K | Sell |
1,277
-4,783
| -79% | -$1.12M | 0.02% | 834 |
|
|
2017
Q4 | $1.36M | Buy |
+6,060
| New | +$1.29M | 0.15% | 206 |
|
|
2017
Q3 | – | Sell |
-1,300
| Closed | -$245K | – | 843 |
|
|
2017
Q2 | $245K | Buy |
+1,300
| New | +$234K | 0.07% | 569 |
|
|
2017
Q1 | – | Sell |
-12,397
| Closed | -$1.78M | – | 1138 |
|
|
2016
Q4 | $1.78M | Buy |
+12,397
| New | +$1.66M | 0.28% | 66 |
|
|
2016
Q3 | – | Sell |
-14,700
| Closed | -$1.93M | – | 790 |
|
|
2016
Q2 | $1.93M | Buy |
14,700
+2,000
| +16% | +$274K | 0.25% | 102 |
|
|
2016
Q1 | $1.76M | Buy |
+12,700
| New | +$1.7M | 0.21% | 147 |
|
|
2015
Q3 | – | Sell |
-16,100
| Closed | -$2.64M | – | 1088 |
|
|
2015
Q2 | $2.64M | Buy |
16,100
+8,800
| +121% | +$1.41M | 0.3% | 29 |
|
|
2015
Q1 | $1.13M | Buy |
+7,300
| New | +$1.04M | 0.12% | 305 |
|
Other funds holding ELV
Trexquant Investment's ELV Position: Q2 2026 in Review
Trexquant Investment increased its Elevance Health (ELV) stake by 28% in Q2 2026, buying an estimated $4.73M and bringing the position to 58,431 shares worth $22.6M. The position accounts for 0.13% of the portfolio, ranked #159.
Trexquant Investment first reported a position in ELV in Q1 2015 and has held it in 27 quarters since. The position peaked at $25.2M in Q2 2025. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Trexquant Investment held 58,431 shares of Elevance Health worth $22.6M as of Q2 2026.
- Trexquant Investment bought 12,752 Elevance Health shares in Q2 2026, an estimated $4.73M.
- Elevance Health made up 0.13% of Trexquant Investment's portfolio in Q2 2026, its #159 holding.
- Trexquant Investment first reported a position in Elevance Health in Q1 2015 and has held it in 27 quarters since.
- Trexquant Investment's Elevance Health position peaked at $25.2M in Q2 2025.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.